Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood for ED and ASD Case Study
NCT06995274Not yet recruiting
- Sponsor
- Cambridge Health Alliance
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Hematopoietic Stem Cells
01
Overview
Open-label, single-arm trial of umbilical cord blood in eosinophilic duodenitis (EoD) and Autism Spectrum Disorder (ASD), sponsored by Cambridge Health Alliance. Primary endpoint: Feasibility and Safety of Umbilical Cord Blood Infusion. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
umbilical cord blood
03
Conditions
eosinophilic duodenitis (EoD)Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT06995274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995274.